These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 14582675)
1. Therapy of alopecia areata: on the cusp and in the future. Price VH J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675 [TBL] [Abstract][Full Text] [Related]
2. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester. Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465 [TBL] [Abstract][Full Text] [Related]
4. The new biologics in psoriasis: possible treatments for alopecia areata. McMichael AJ J Investig Dermatol Symp Proc; 2003 Oct; 8(2):217-8. PubMed ID: 14582677 [TBL] [Abstract][Full Text] [Related]
5. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction. Gao Z; Jin YQ; Wu W Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931 [TBL] [Abstract][Full Text] [Related]
6. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model. Nakamura M; Jo J; Tabata Y; Ishikawa O Am J Pathol; 2008 Mar; 172(3):650-8. PubMed ID: 18245811 [TBL] [Abstract][Full Text] [Related]
7. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder]. Freyschmidt-Paul P; Happle R; Hoffman R J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322 [TBL] [Abstract][Full Text] [Related]
8. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Zhang JG; Oliver RF Br J Dermatol; 1994 Apr; 130(4):405-14. PubMed ID: 7910477 [TBL] [Abstract][Full Text] [Related]
9. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450 [TBL] [Abstract][Full Text] [Related]